SinoVac

Entstehender Artikel

科兴控股生物技术有限公司 Eigentlich Coronavac

Freie Übersichtsartikel	^[1]^[2]^[3]
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

Bibliographie

↑ Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181-192. doi:10.1016/S1473-3099(20)30843-4
↑ Drugs and Lactation Database (LactMed) [Internet. Bethesda (MD): National Library of Medicine (US); 2006-. COVID-19 vaccines. [Updated 2021 Oct 18].] Available from: https://www.ncbi.nlm.nih.gov/books/NBK565969/
↑ Silva VO, Yamashiro R, Ahagon CM, de Campos IB, de Oliveira IP, de Oliveira EL, López-Lopes GIS, Matsuda EM, Castejon MJ, de Macedo Brígido LF. Inhibition of receptor-binding domain-ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines. J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27396. Epub ahead of print. PMID: 34647623.